Management of T-Cell Lymphoma: In Quest of the Holy Grail
- PMID: 34208034
- PMCID: PMC8230632
- DOI: 10.3390/cancers13122919
Management of T-Cell Lymphoma: In Quest of the Holy Grail
Abstract
T-cell lymphomas (TCL) represent a very heterogeneous group of lymphoid tumors which are clearly distinct from B-cell neoplasms [...].
Conflict of interest statement
The author declares no conflict of interest.
Figures
References
-
- Swerdlow S.H., Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H., Thiele J., Vardiman J. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Publisher; Lyon, France: 2017.
-
- Laurent C., Baron M., Amara N., Haioun C., Dandoit M., Maynadié M., Parrens M., Vergier B., Copie-Bergman C., Fabiani B., et al. Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of patients from the French Lymphopath network. J. Clin. Oncol. 2017;35:2008–2017. doi: 10.1200/JCO.2016.71.2083. - DOI - PubMed
-
- Paul S., Pearlman A.H., Douglass J., Mog B.J., Hsiue E.H., Hwang M.S., DiNapoli S.R., Konig M.F., Brown P.A., Wright K.M., et al. TCR β chain–directed bispecific antibodies for the treatment of T cell cancers. Sci. Transl. Med. 2021;13:eabd3595. doi: 10.1126/scitranslmed.abd3595. - DOI - PMC - PubMed
-
- Ottolini B., Nawaz N., Trethewey C.S., Mamand S., Allchin R.L., Dillon R., Fields P.A., Ahearne M.J., Wagner S.D. Multiple mutations at exon 2 of RHOA detected in plasma from patients with peripheral T-cell lymphoma. Blood Adv. 2020;4:2392–2403. doi: 10.1182/bloodadvances.2019001075. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources